Associate Director / Director Business Development, HEOR, RWE, & Market Access

Health Economists Jobs at Open Health

Home-based, US. OPEN Health’s Business Development team is looking to add an experienced team member to support growth efforts in the Evidence & Access (HEOR, RWE, and Market Access) practice. The role will be focused on proactive, outbound business development within established key accounts. Essential Duties & Responsibilities: Identifying key client decision makers across multiple disciplines (including procurement, scientific, and … Read more

Director, In-line Brands – Global Health Economics, Value, & Outcomes

Teva pharmaceuticals health economics jobs

Parsippany, NJ, US. As the Director, In-line Brands – Global health Economics, Value, and Outcomes, you will serve as the principal strategic and technical lead for UZEDY in the Neuroscience TA, primarily focused on the US market. You will develop and implement comprehensive evidence generation plans, including clinical, economic and humanistic evidence to meet the needs of different external stakeholders … Read more

Senior Director, Pipeline Head for Neuroscience, Global Health Economics, Value, & Outcomes

Teva pharmaceuticals health economics jobs

Harlow, UK / Amsterdam, Netherlands. Other locations: West Chester, PA; Parsippany, NJ, US. The goals and objectives of the Global Health Economics, Value, and Outcomes department is to develop robust value and evidence strategies supportive of the value of pipeline and BD assets in clinical development; formulate evidence-based value propositions that are aligned with Teva assets and products and have a … Read more

Senior Director, Pipeline Head for Immunology, Global Health Economics, Value, & Outcomes

Teva pharmaceuticals health economics jobs

Harlow, UK / Amsterdam, Netherlands. Other locations: West Chester, PA; Parsippany, NJ, US. The goals and objectives of the Global Health Economics, Value, and Outcomes department is to develop robust value and evidence strategies supportive of the value of pipeline and BD assets in clinical development; formulate evidence-based value propositions that are aligned with Teva assets and products and have … Read more

RWE Manager

Jobs at Novo Nordisk for Health Economists

Seoul, South Korea. Are you passionate about driving strategic initiatives and programs in the field of Real World Evidence (RWE)? Do you have experience in managing teams and engaging with stakeholders? If so, we have an exciting opportunity for you to join our Clinical, Medical, Regulatory Affairs (CMR) department as a Real World Evidence Manager. Read on to learn more … Read more

Senior Director, Pipeline Head for Immunology, Global Health Economics, Value, & Outcomes

Teva pharmaceuticals health economics jobs

West Chester, PA / Parsippany, NJ, US. The ideal candidate will need to be based out of our West Chester, Pennsylvania or Parsippany, New Jersey.  The goals and objectives of the Global Health Economics, Value, and Outcomes department is to develop robust value and evidence strategies supportive of the value of pipeline and BD assets in clinical development; formulate evidence-based … Read more

HEOR Manager

MSD Health Economics jobs

Brussels, Belgium. For our location in Brussels, we are currently recruiting a: Health Economics and Outcomes Research Manager. In this role you will help to shape and implement the company’s position in this area in order to capitalize on the opportunities of real-world data and to address potential challenges. Do you have a scientific Master’s or PhD degree and experience … Read more

Manager HEOR / RWD

Jobs at Daiichi Sankyo for Health Economists

Munich, Germany. Ab sofort suchen wir bei der Daiichi Sankyo Deutschland GmbH eine/n engagierte/n Manager HEOR/RWD Oncology (m/w/d). Angaben zur Tätigkeit: In Ihrer Funktion arbeiten Sie in enger Abstimmung mit dem Lead HEOR & RWD Manager Oncology an folgenden Aufgaben: Entwicklung von Studienkonzepten sowie Koordination und Durchführung von Projekten zur Evidenzgenerierung mit dem Ziel, Daten aus dem deutschen Versorgungskontext zu … Read more

RWE Business Liaison Lead

Health Economists jobs at UCB

Shanghai, China. We are looking for a Real-World Evidence Business Liaison China who is supportive, multi-tasking and energetic to join us in our RWD team, based in our UCB SH Office. What you’ll do: Ensures transparency and translation of RWE strategies from global to local. Clearly communicates and interprets guidance and frameworks to the region. Ensures that research within the region is coordinated with … Read more

Senior RWE Scientist

Jobs at AstraZeneca for Health Economists

Barcelona, Spain. We are looking for MSc/PhD level epidemiologists, bio-statisticians, biomedical data scientists, clinicians/pharmacologists or related fields with a strong desire to learn and expand their abilities into the analysis of Real World Evidence (RWE). The ideal candidate for this role will have deep understanding of epidemiology and will bring a consistent track record of delivering value through the use … Read more

Director, RWE Partnerships & Innovation

Pfizer Health Economists jobs

Tokyo, Japan / Seoul, South Korea. Other location: Mapletree Business City, Singapore. The Platform: The Chief Medical Affairs Office’s  RWE Partnerships and Platforms organization is responsible for establishing global RWE data and scientific leadership through the generation of integrated, end-to-end observational real-world evidence serving all therapeutic areas from proof of concept (POC) trials through LOE for priority pipeline candidates, pipeline … Read more

(Sr.) Consultant, HEOR, Real World Solutions

Health Economists jobs at IQVIA

Petaling Jaya, Malaysia. Our HEOR team includes highly qualified multi-disciplinary experts. They are based throughout Asia with a focused footprint in the SEA. The HEOR practice is part of the IQVIA Real-World Insights business unit that connects healthcare stakeholders through knowledge, skills, practical experience, creativity and data to demonstrate the value of medicines, enhance quality of care and drive improvement … Read more

Analyst – Assoc Consultant, HEOR, Real World Solutions

Health Economists jobs at IQVIA

Singapore. Our HEOR team includes highly qualified multi-disciplinary experts. They are based throughout Asia with a focused footprint in the SEA. The HEOR practice is part of the IQVIA Real-World Insights business unit that connects healthcare stakeholders through knowledge, skills, practical experience, creativity and data to demonstrate the value of medicines, enhance quality of care and drive improvement of patient … Read more

Associate Director, RWE Analytics

Jazz Pharmaceuticals Health Economics Jobs

Harrisburg, PA, US. The Associate Director of RWE analytics will be responsible for providing strategic direction, overseeing the execution of RWE analytics projects, and driving innovation within the RWE analytics team. The successful candidate will possess a deep understanding of RWE methodologies, exceptional leadership skills and a proven track record in delivering high-quality RWE analytic projects. The Associate Director will … Read more

HEOR and RWE Senior Manager

Thermo Fisher Scientific Jobs for Health Economists

Home-based, US / UK. Other locations: Home-based, Greece; Portugal; Barcelona, Spain; France; Milan, Italy; Discover Impactful Work: The Sr. Manager, Health Economics and Outcomes Research (HEOR) & Real-World Evidence will be responsible for supporting the development and execution of global HEOR and RWE activities to support the Binding Site’s existing portfolio and pipeline products. This individual will play a key … Read more

Real-World Evidence in Health Economics

RWE jobs in Health Economics
Real-World Evidence in Health Economics

Real-world evidence (RWE) has become an increasingly important aspect of health economics research in recent years. It provides a comprehensive and in-depth understanding of how different health interventions work in real-world settings.

What is Real-World Evidence?

Real-world evidence (RWE) is defined as data collected from sources other than traditional randomized controlled trials (RCTs). These data come from a variety of sources, including electronic health records (EHRs), claims databases, registries, patient-reported outcomes (PROs), and surveys.

RWE allows researchers to evaluate the effectiveness, safety, and cost-effectiveness of health interventions in real-world settings. This is important because RCTs often have strict inclusion and exclusion criteria, which means that the results may not be generalizable to real-world populations.

Importance of Real-World Evidence in Health Economics

RWE is becoming increasingly important in health economics because it provides a more complete picture of the effectiveness and safety of health interventions. By using RWE, researchers can evaluate how interventions work in a variety of settings and patient populations, which can help inform clinical practice and policy decisions.

RWE can also be used to conduct cost-effectiveness analyses, which help policymakers determine the value of health interventions. Cost-effectiveness analyses compare the costs and benefits of different health interventions, taking into account the costs of the intervention as well as the costs of any adverse events or complications that may occur.

Differences between RWE and Randomized Controlled Trials (RCTs)

RCTs are considered the gold standard for evaluating the effectiveness and safety of health interventions. However, there are several key differences between RWE and RCTs.

RCTs are conducted under controlled conditions and have strict inclusion and exclusion criteria, which means that the results may not be generalizable to real-world populations. RWE, on the other hand, is collected from a variety of sources and reflects the real-world experiences of patients.

RCTs also tend to be shorter in duration than RWE studies, which means that they may not capture the long-term effects of health interventions. RWE studies, on the other hand, can provide information on the long-term effectiveness and safety of interventions.

Methods of Collecting RWE

There are several methods of collecting RWE, including:

Electronic Health Records (EHRs)
EHRs are digital records of patient health information that are maintained by healthcare providers. EHRs can provide a wealth of information on patient demographics, diagnoses, treatments, and outcomes.

Claims Databases
Claims databases contain information on healthcare services and medications that are billed to insurance providers. Claims data can provide information on healthcare utilization, costs, and outcomes.

Registries
Registries are databases that collect information on specific diseases or health conditions. They can provide valuable information on disease prevalence, treatment patterns, and outcomes.

Patient-Reported Outcomes (PROs)
PROs are questionnaires or surveys completed by patients that assess their health status, symptoms, and quality of life. PROs can provide information on patient preferences and experiences with different interventions.

Surveys
Surveys can be used to collect information on patient demographics, health behaviors, and healthcare utilization. They can also be used to assess patient preferences and satisfaction with different interventions.

Advantages of Real-World Evidence

There are several advantages of using RWE in health economics research, including:

  • RWE reflects real-world experiences and can provide a more comprehensive understanding of the effectiveness and safety of interventions.
  • RWE can be used to evaluate interventions in a variety of settings and patient populations.
  • RWE can provide information on the long-term effectiveness and safety of interventions.
  • RWE can be used to conduct cost-effectiveness analyses, which can inform clinical practice and policy decisions.

Challenges and Limitations of Real-World Evidence

There are several challenges and limitations to using RWE in health economics research, including:

  • RWE can be subject to bias and confounding, which can affect the validity of the results.
  • RWE can be difficult to collect and analyze, particularly when using multiple data sources.
  • RWE may not be as well-suited for evaluating rare diseases or interventions.

Applications of Real-World Evidence

RWE has several applications in health economics research, including:

Health Technology Assessment
Health technology assessment (HTA) is a process that evaluates the clinical effectiveness, safety, and cost-effectiveness of new health technologies. RWE can be used in HTA to provide information on the real-world effectiveness and safety of interventions.

Comparative Effectiveness Research
Comparative effectiveness research (CER) compares the effectiveness of different interventions for the same health condition. RWE can be used in CER to compare the effectiveness of interventions in different patient populations and settings.

Post-Marketing Surveillance
Post-marketing surveillance is the process of monitoring the safety and effectiveness of new drugs and medical devices after they have been approved for use. RWE can be used in post-marketing surveillance to monitor the long-term safety and effectiveness of interventions.

Future of Real-World Evidence in Health Economics

RWE is likely to become increasingly important in health economics research in the future. Advances in technology and data analytics are making it easier to collect and analyze RWE, and policymakers are recognizing the importance of using RWE to inform clinical practice and policy decisions.